MyFinsight
Home
Blog
About
ELUTIA INC. (ELUT)
ELUTIA INC. (ELUT)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$8,592K
Free Cash flow
-$8,552K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Insurance receivables of litigat...
Stock-based compensation
Prepaid expenses and other
Others
Negative Cash Flow Breakdown
Net loss
Contingent liability for legal p...
Accounts payable and accrued exp...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-7,646
-7,469
70,791
-3,868
Depreciation and amortization
349
330
297
728
Gain on sale of orthobiologics business
0
425
80,211
-
Loss on early repayment of debt
-
-
-1,287
-
(gain) loss on revaluation of warrant liability
-226
1,655
-906
-5,098
Amortization of deferred financing costs and debt discount
-
-
-
54
Interest expense recorded as additional revenue interest obligation or long-term debt
140
145
-65
1,246
Stock-based compensation
905
931
872
1,982
Bad debt expense
-
-
458
-
Changes in right-of-use assets and lease liabilities and lease incentives received
88
320
-
-
Payments on revenue interest obligation
1,100
-
2,200
-
Other
-
-
-608
-
Accounts receivable
-630
334
-1,361
403
Inventory
-8
40
548
-239
Insurance receivables of litigation costs
-1,496
502
285
264
Prepaid expenses and other
-651
-241
2,183
-745
Accounts payable and accrued expenses
-1,358
542
-9,855
2,287
Contingent liability for legal proceedings
-2,398
-3,225
-5,142
-632
Other liabilities
-
-
1,068
97
Net cash used in operating activities
-8,461
-7,831
-24,814
-2,887
Proceeds from sale of orthobiologics business
0
425
80,435
-
Expenditures for property and equipment
91
459
854
630
Net cash used in investing activities
-91
-34
79,581
-630
Proceeds from public offering or private placement with warrants, net of offering costs
-
-
13,795
-
Proceeds from private placement and warrants, net of offering costs
-
-
-
0
Proceeds (repayments) of long-term debt, net
-
-
-23,064
-
Repayments of insurance premium financings
-
-
0
236
Payments for taxes upon vesting of restricted stock units
42
44
73
58
Proceeds from stock option exercises and issuance common stock under espp
2
47
0
32
Net cash provided by (used in) financing activities
-40
3
-23,138
-262
Net (decrease) increase in cash and cash equivalents
-8,592
-7,862
31,629
-3,779
Cash and cash equivalents, beginning of period
28,488
36,350
4,721
13,239
Cash and cash equivalents, end of period
19,896
28,488
36,350
4,721
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net (decrease)
increase in cash and cash...
-$8,592K
(-81.30%↓ Y/Y)
Insurance receivables of
litigation costs
-$1,496K
(-223.11%↓ Y/Y)
Stock-based compensation
$905K
(-61.65%↓ Y/Y)
Prepaid expenses and
other
-$651K
(43.54%↑ Y/Y)
Accounts receivable
-$630K
(-172.08%↓ Y/Y)
Depreciation and
amortization
$349K
(-80.17%↓ Y/Y)
Interest expense
recorded as additional...
$140K
(-94.71%↓ Y/Y)
Changes in right-of-use
assets and lease...
$88K
Inventory
-$8K
(-100.60%↓ Y/Y)
Proceeds from stock
option exercises and...
$2K
(-97.50%↓ Y/Y)
Net cash used in
operating activities
-$8,461K
(50.55%↑ Y/Y)
Net cash used in
investing activities
-$91K
(76.79%↑ Y/Y)
Net cash provided by
(used in) financing...
-$40K
(-100.31%↓ Y/Y)
Canceled cashflow
$4,267K
Canceled cashflow
$2K
Net loss
-$7,646K
(43.54%↑ Y/Y)
Contingent liability for
legal proceedings
-$2,398K
(29.82%↑ Y/Y)
Expenditures for property and
equipment
$91K
(-76.79%↓ Y/Y)
Payments for taxes upon
vesting of restricted...
$42K
(-83.13%↓ Y/Y)
Accounts payable and
accrued expenses
-$1,358K
(-233.01%↓ Y/Y)
Payments on revenue
interest obligation
$1,100K
(gain) loss on
revaluation of warrant...
-$226K
(96.95%↑ Y/Y)
Buy us a coffee